TG Therapeutics, Inc. posted a strong Q3 with soaring Briumvi sales and increased guidance. Click for my updated look at TGTX stock post earnings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback